{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:05:02Z","timestamp":1762506302109},"reference-count":31,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["humanpathol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.humpath.2014.03.001","type":"journal-article","created":{"date-parts":[[2014,3,26]],"date-time":"2014-03-26T12:15:36Z","timestamp":1395836136000},"page":"1496-1503","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Prognostic comparison of proliferation markers and World Health Organization 1973\/2004 grades in urothelial carcinomas of the urinary bladder"],"prefix":"10.1016","volume":"45","author":[{"given":"Ok M\u00e5lfrid","family":"Mangrud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Einar","family":"Gudlaugsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivar","family":"Skaland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilker","family":"Tasdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingvild","family":"Dalen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"van Diermen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan P.A.","family":"Baak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiel A.M.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2014.03.001_bb0005","series-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs","first-page":"110","year":"2004"},{"issue":"6 Suppl 1","key":"10.1016\/j.humpath.2014.03.001_bb0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.urology.2005.07.062","article-title":"Bladder cancer: epidemiology, staging and grading, and diagnosis","volume":"66","author":"Kirkali","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.humpath.2014.03.001_bb0160","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/00365590310008037","article-title":"A population-based study of 538 patients with newly detected urinary bladder neoplasms followed during 5 years","volume":"37","author":"Larsson","year":"2003","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.humpath.2014.03.001_bb0165","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/S0022-5347(01)67321-X","article-title":"The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years","volume":"153","author":"Holmang","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2014.03.001_bb0025","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2013.06.003","article-title":"EAU Guidelines on non\u2013muscle-invasive urothelial carcinoma of the bladder: Update 2013","volume":"64","author":"Babjuk","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2014.03.001_bb0030","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00000478-199812000-00001","article-title":"The World Health Organization\/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee","volume":"22","author":"Epstein","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2014.03.001_bb0035","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00428-011-1072-3","article-title":"Histologic grading of urothelial papillary neoplasms: impact of combined grading (two-numbered grading system) on reproducibility","volume":"458","author":"Tuna","year":"2011","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2014.03.001_bb0040","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000100839","article-title":"Comparison of 1998 WHO\/ISUP and 1973 WHO classifications for interobserver variability in grading of papillary urothelial neoplasms of the bladder. Pathological evaluation of 258 cases","volume":"78","author":"Gonul","year":"2007","journal-title":"Urol Int"},{"key":"10.1016\/j.humpath.2014.03.001_bb0045","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/01.ju.0000055471.78783.ae","article-title":"Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder","volume":"169","author":"Bol","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2014.03.001_bb0050","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/jcp.54.11.854","article-title":"Improved objectivity of grading of T(A,1) transitional cell carcinomas of the urinary bladder by quantitative nuclear and proliferation related features","volume":"54","author":"Bol","year":"2001","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2014.03.001_bb0175","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0090-4295(02)01906-4","article-title":"Prognostic value of proliferative activity and nuclear morphometry for progression in TaT1 urothelial cell carcinomas of the urinary bladder","volume":"60","author":"Bol","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.humpath.2014.03.001_bb0060","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/jclinpath-2011-200532","article-title":"Scoring the percentage of Ki67 positive nuclei is superior to mitotic count and the mitosis marker phosphohistone H3 (PHH3) in terms of differentiating flat lesions of the bladder mucosa","volume":"65","author":"Gunia","year":"2012","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2014.03.001_bb0170","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1200\/JCO.2003.05.073","article-title":"Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome","volume":"21","author":"vanRhijn","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2014.03.001_bb0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10549-008-9980-x","article-title":"Validating the prognostic value of proliferation measured by phosphohistone H3 (PPH3) in invasive lymph node\u2013negative breast cancer patients less than 71 years of age","volume":"114","author":"Skaland","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.humpath.2014.03.001_bb0075","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1365-2559.2012.04329.x","article-title":"Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancer","volume":"61","author":"Gudlaugsson","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2014.03.001_bb0080","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/jcp.56.6.447","article-title":"Proliferation markers and DNA content analysis in urinary bladder TaT1 urothelial cell carcinomas: identification of subgroups with low and high stage progression risks","volume":"56","author":"Bol","year":"2003","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2014.03.001_bb0085","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/cncr.10733","article-title":"Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder","volume":"95","author":"Pich","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2014.03.001_bb0090","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/DAD.0b013e31823135a3","article-title":"pHH3 immunostaining improves interobserver agreement of mitotic index in thin melanomas","volume":"34","author":"Schimming","year":"2012","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.humpath.2014.03.001_bb0095","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/modpathol.2012.188","article-title":"Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I\/II melanoma","volume":"26","author":"Nielsen","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2014.03.001_bb0100","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1002\/1097-0142(20000601)88:11<2598::AID-CNCR24>3.0.CO;2-N","article-title":"MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder: clinical significance and comparison with other prognostic factors","volume":"88","author":"Oosterhuis","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2014.03.001_bb0105","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/jcp.2004.022939","article-title":"Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder","volume":"59","author":"Quintero","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2014.03.001_bb0110","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.eururo.2013.03.043","article-title":"Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy","volume":"64","author":"Lotan","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2014.03.001_bb0115","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.clgc.2013.05.001","volume":"11","author":"Otto","year":"2013","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.humpath.2014.03.001_bb0120","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)66443-9","article-title":"Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy","volume":"165","author":"Holmang","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2014.03.001_bb0125","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/modpathol.3800675","article-title":"Survivin nuclear labeling index: a superior biomarker in superficial urothelial carcinoma of human urinary bladder","volume":"19","author":"Yin","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2014.03.001_bb0130","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/jnci\/djt306","article-title":"An international ki67 reproducibility study","volume":"105","author":"Polley","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.humpath.2014.03.001_bb0135","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.eururo.2006.11.025","article-title":"On the origin of syn- and metachronous urothelial carcinomas","volume":"51","author":"Hoglund","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2014.03.001_bb0140","doi-asserted-by":"crossref","first-page":"546917","DOI":"10.1155\/2012\/546917","article-title":"Epigenetic alterations in bladder cancer and their potential clinical implications","volume":"2012","author":"Han","year":"2012","journal-title":"Adv Urol"},{"key":"10.1016\/j.humpath.2014.03.001_bb0145","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0002-9440(10)64665-2","article-title":"Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors","volume":"158","author":"Billerey","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2014.03.001_bb0150","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1158\/0008-5472.CAN-03-2421","article-title":"FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma","volume":"64","author":"van Rhijn","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2014.03.001_bb0155","doi-asserted-by":"crossref","first-page":"e57284","DOI":"10.1371\/journal.pone.0057284","article-title":"Fibroblast growth factor receptors-1 and -3 play distinct roles in the regulation of bladder cancer growth and metastasis: implications for therapeutic targeting","volume":"8","author":"Cheng","year":"2013","journal-title":"PLoS One"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681771400118X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681771400118X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T19:19:40Z","timestamp":1565291980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004681771400118X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S004681771400118X"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2014.03.001","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic comparison of proliferation markers and World Health Organization 1973\/2004 grades in urothelial carcinomas of the urinary bladder","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2014.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}